Network origin in Yi Feng Shi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yi Feng Shi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Thomas Jefferson University | College/University | Doctorate Degree | |
| FORMOSA LABORATORIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree | |
| ATOSSA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| The Johns Hopkins University | College/University | Graduate Degree | |
| SIRNAOMICS LTD. | Biotechnology | Director/Board Member | |
Charter Medical Ltd.
 Charter Medical Ltd. BiotechnologyHealth Technology Charter Medical has an established history of providing specialty products to the blood transfusion and cell therapies and single-use bioprocessing containers to the biotechnology and pharmaceutical markets. Charter Medical was formed in 1998, a privately held medical device manufacturer of disposable blood transfusion and intravenous products located in Lakewood, NJ. Charter Medical continued production of the existing CharterMed medical devices and expanded the product line to include bioprocessing bags. Manufacturing began at the Winston-Salem headquarters in 1998 in one ISO Class 8 cleanroom. In 2001, Charter Medical commissioned a second cleanroom at the 71,000 square foot site to expand the medical device and bioprocessing bag manufacturing capabilities. Through a second expansion in 2009, Charter Medical now houses 15,000 square feet of clean room space to support the ever growing demand for disposable products. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Shanghai Furen Medicine R&D Co., Ltd. | Corporate Officer/Principal | ||
| University of Science & Technology of China | College/University | Undergraduate Degree | |
| Tokyo Institute of Technology | College/University | Graduate Degree | |
| Aalto University School of Science & Technology | College/University | Doctorate Degree |
Statistics
International
| United States | 9 |
| China | 3 |
| Taiwan | 2 |
| Hong Kong | 2 |
| Japan | 2 |
Sectoral
| Consumer Services | 7 |
| Health Technology | 7 |
| Commercial Services | 2 |
Operational
| Corporate Officer/Principal | 7 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 2 |
| General Counsel | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Yong Xiang Wang | 10 |
| Ben R. Chen | 5 |
| Heather D. Malicki | 2 |
- Stock Market
- Insiders
- Yi Feng Shi
- Company connections
